A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults

NCT02481947 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

459

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Idiopathic Constipation

Interventions

DRUG: BLI400 Laxative
DRUG: Lubiprostone

Sponsor

Braintree Laboratories